Works matching IS 15460096 AND DT 2015 AND VI 13 AND IP 1

Results: 42
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Evaluation of a Rheumatology Transition Clinic.

    Published in:
    Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/s12969-015-0016-x
    By:
    • Stringer, Elizabeth;
    • Scott, Rachel;
    • Mosher, Dianne;
    • MacNeill, Inez;
    • Huber, Adam M.;
    • Ramsey, Suzanne;
    • Lang, Bianca
    Publication type:
    Article
    23
    24
    25
    26

    Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.

    Published in:
    Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
    By:
    • Kostik, Mikhail M.;
    • Dubko, Margarita F.;
    • Masalova, Vera V.;
    • Snegireva, Ludmila S.;
    • Kornishina, Tatyana L.;
    • Chikova, Irina A.;
    • Isupova, Eugenia A.;
    • Kuchinskaya, Ekaterina M.;
    • Glebova, Natalia I.;
    • Buchinskaya, Natalia V.;
    • Kalashnikova, Olga V.;
    • Chasnyk, Vyacheslav G.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.

    Published in:
    Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
    By:
    • Kostik, Mikhail M.;
    • Dubko, Margarita F.;
    • Masalova, Vera V.;
    • Snegireva, Ludmila S.;
    • Kornishina, Tatyana L.;
    • Chikova, Irina A.;
    • Isupova, Eugenia A.;
    • Kuchinskaya, Ekaterina M.;
    • Glebova, Natalia I.;
    • Buchinskaya, Natalia V.;
    • Kalashnikova, Olga V.;
    • Chasnyk, Vyacheslav G.
    Publication type:
    Article
    38
    39

    Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.

    Published in:
    Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
    By:
    • Kostik, Mikhail M.;
    • Dubko, Margarita F.;
    • Masalova, Vera V.;
    • Snegireva, Ludmila S.;
    • Kornishina, Tatyana L.;
    • Chikova, Irina A.;
    • Isupova, Eugenia A.;
    • Kuchinskaya, Ekaterina M.;
    • Glebova, Natalia I.;
    • Buchinskaya, Natalia V.;
    • Kalashnikova, Olga V.;
    • Chasnyk, Vyacheslav G.
    Publication type:
    Article
    40

    Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.

    Published in:
    Pediatric Rheumatology, 2015, v. 13, n. 1, p. 1, doi. 10.1186/1546-0096-13-4
    By:
    • Kostik, Mikhail M.;
    • Dubko, Margarita F.;
    • Masalova, Vera V.;
    • Snegireva, Ludmila S.;
    • Kornishina, Tatyana L.;
    • Chikova, Irina A.;
    • Isupova, Eugenia A.;
    • Kuchinskaya, Ekaterina M.;
    • Glebova, Natalia I.;
    • Buchinskaya, Natalia V.;
    • Kalashnikova, Olga V.;
    • Chasnyk, Vyacheslav G.
    Publication type:
    Article
    41
    42